Orphan drugs and regulatory affairs

on May 19, 2015 Watching and reading and Tags: with 0 comments

I watched the live broadcast of “Orphan Drug & Rare Disease Development: Understanding the European and US Regulatory Landscape” today, hosted by XTalks and presented by Premier Research. Talking about the US regulatory scene, Nach Dave emphasised that orphan drugs spend less time in clinical trials, have a better chance of obtaining FDA approval, and […]

Read more